HomeNewsBusinessCompaniesAurobindo gets final US FDA nod for hypertension drug

Aurobindo gets final US FDA nod for hypertension drug

Aurobindo Pharma has received final approval from the US Food and Drugs Administration to manufacture and market Ramipril capsules, which are used for the treatment of hypertension.

June 10, 2011 / 15:41 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Moneycontrol Bureau

Aurobindo Pharma has received final approval from the US Food and Drugs Administration to manufacture and market Ramipril capsules, which are used for the treatment of hypertension.

Aurobindo

first published: Jun 10, 2011 01:31 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347